Page 111 - AN-1-2
P. 111

Advanced Neurology                                                             Genetics in PD hyposmia



               Neuro, 55(1): 84–90.                               https://doi.org/10.1002/mds.23429
               https://doi.org/10.1001/archneur.55.1.84        14.  Chaudhuri KR, Martinez-Martin P, Schapira AH, et al.,
            3.   Marin C, Vilas D, Langdon C, et al., 2018, Olfactory   2006,  International  multicenter  pilot  study  of  the  first
               dysfunction in neurodegenerative diseases.  Curr Allergy   comprehensive  self-completed  nonmotor  symptoms
               Asthma Rep, 18(8): 42.                             questionnaire for parkinson’s disease: The NMSQuest study.
                                                                  Mov Disord, 21(7): 916–923.
               https://doi.org/10.1007/s11882-018-0796-4
                                                                  https://doi.org/10.1002/mds.20844
            4.   Haehner A, Boesveldt S, Berendse HW, et al., 2009,
               Prevalence of smell loss in Parkinson’s disease-a multicenter   15.  Cecchini MP, Federico A, Zanini A, et al., 2019, Olfaction
               study. Parkinsonism Relat Disord, 15(7): 490–494.  and taste in parkinson’s disease: The association with mild
                                                                  cognitive impairment and the single cognitive domain
               https://doi.org/10.1016/j.parkreldis.2008.12.005   dysfunction. J Neural Transm (Vienna), 126(5): 585–595.
            5.   Rossi M, Escobar AM, Bril A, et al., 2016, Motor features      https://doi.org/10.1007/s00702-019-01996-z
               in Parkinson’s disease with normal olfactory function. Mov
               Disord, 31(9): 1414–1417.                       16.  Li K, Ge YL, Gu CC, et al., 2020, Substantia nigra echogenicity
                                                                  is associated with serum ferritin, gender and iron-related
               https://doi.org/10.1002/mds.26687                  genes in parkinson’s disease. Sci Rep, 10(1): 8660.
            6.   Gisladottir RS, Ivarsdottir EV, Helgason A, et al., 2020,      https://doi.org/10.1038/s41598-020-65537-5
               Sequence variants in TAAR5 and other loci affect human
               odor perception and naming. Curr Biol, 30(23): 4643–4653.  17.  Zhang JR, Jin H, Li K, et al., 2018, Genetic analysis of LRRK2
                                                                  in Parkinson’s disease in Han Chinese population. Neurobiol
               https://doi.org/10.1016/j.cub.2020.09.012
                                                                  Aging, 72: 187.e5–187.e10.
            7.   Sobhani S, Rahmani F, Aarabi MH, et al., 2019, Exploring
               white  matter  microstructure and  olfaction  dysfunction  in      https://doi.org/10.1016/j.neurobiolaging.2018.06.036
               early parkinson disease: Diffusion MRI reveals new insight.   18.  Shi YY, He L, 2005, SHEsis, a powerful software platform for
               Brain Imaging Behav, 13(1): 210–219.               analyses of linkage disequilibrium, haplotype construction,
                                                                  and genetic association at polymorphism loci.  Cell Res,
               https://doi.org/10.1007/s11682-017-9781-0
                                                                  15(2): 97–98. https://doi.org/10.1038/sj.cr.7290272
            8.   Thaler A, Bregman N, Gurevich T, et al., 2018, Parkinson’s
               disease phenotype is influenced by the severity of the   19.  Ascherio A, Schwarzschild MA, 2016, The epidemiology
               mutations  in  the  GBA  gene.  Parkinsonism Relat Disord,   of Parkinson’s disease: Risk factors and prevention. Lancet
               55: 45–49.                                         Neurol, 15(12): 1257–1272.
                                                                  https://doi.org/10.1016/s1474-4422(16)30230-7
               https://doi.org/10.1016/j.parkreldis.2018.05.009
            9.   Da Silva CP, Aberu GD, Acero PH, et al., 2017, Clinical   20.  Cheng XY, Mao CJ, Wang YL, et al., 2022, Gastrointestinal
               profiles associated with LRRK2 and GBA mutations   symptoms of Parkinson’s disease: A systematic review from
               in Brazilians with Parkinson’s disease.  J  Neurolo  Sci,   pathogenesis to management. Adv Neurol, 1(1): 53.
               381: 160–164.                                      https://doi.org/10.36922/an.v1i1.9
               https://doi.org/10.1016/j.jns.2017.08.3249      21.  Boesveldt S, Verbaan D, Knol D, et al., 2007, Assessment of
            10.  Postuma RB, Berg D, Stern M, et al., 2015, MDS clinical   odor identification and discrimination in dutch parkinson’s
               diagnostic criteria for Parkinson’s disease.  Mov Disord,   disease patients. Mov Disord, 22: S161.
               30(12): 1591–1601.                              22.  Bohnen NI, Gedela S, Kuwabara H, et al., 2007, Selective
               https://doi.org/10.1002/mds.26424                  hyposmia and nigrostriatal dopaminergic denervation in
                                                                  Parkinson’s disease. J Neurol, 254(1): 84–90.
            11.  Daniel SE, Lees AJ, 1993, Parkinson’s disease society brain
               bank,  London:  overview  and  research.  J  Neural Transm      https://doi.org/10.1007/s00415-006-0284-y
               Suppl, 39: 165–172.                             23.  Double KL, Rowe DB, Hayes M, et al., 2003, Identifying
            12.  Martínez-Martín P, Gil-Nagel A, Gracia LM,  et al., 1994,   the pattern of olfactory deficits in Parkinson disease
               Unified parkinson’s disease rating scale characteristics and   using the brief smell identification test.  Arch Neurol,
               structure. The cooperative multicentric group. Mov Disord,   60(4): 545–549.
               9(1): 76–83.                                       https://doi.org/10.1001/archneur.60.4.545
               https://doi.org/10.1002/mds.870090112           24.  Espinoza S, Sukhanov I, Efimova EV, et al., 2020, trace
            13.  Tomlinson CL, Stowe R, Patel S,  et al., 2010, Systematic   amine-associated receptor 5 provides olfactory input into
               review of levodopa dose equivalency reporting in parkinson’s   limbic brain areas and modulates emotional behaviors and
               disease. Mov Disord, 25(15): 2649–2653.            serotonin transmission. Front Mol Neurosci, 13: 18.


            Volume 1 Issue 2 (2022)                         5                        https://doi.org/10.36922/an.v1i2.71
   106   107   108   109   110   111   112   113   114   115   116